{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:49:28Z","timestamp":1758476968699},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1001\/jamainternmed.2018.0869","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T16:30:37Z","timestamp":1525105837000},"page":"743","source":"Crossref","is-referenced-by-count":9,"title":["Concerns About the Approval of Nusinersen Sodium by the US Food and Drug Administration"],"prefix":"10.1001","volume":"178","author":[{"given":"Martha S.","family":"Gerrity","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine and Geriatrics, Oregon Health & Sciences University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Knight Cancer Institute, Portland, Oregon"},{"name":"Center for Health Care Ethics, Oregon Health & Sciences University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Obley","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Geriatrics, Oregon Health & Sciences University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"18","key":"ivp180007r2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy.","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"ivp180007r4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ana.v81.3","article-title":"Emerging therapies and challenges in spinal muscular atrophy.","volume":"81","author":"Farrar","year":"2017","journal-title":"Ann Neurol"},{"issue":"7","key":"ivp180007r9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy.","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"ivp180007r1","unstructured":"Center for Drug Evaluation and Research, US Food and Drug Administration. Application number: 209531Orig1s000: office director memo. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000ODMemo.pdf. Accessed January 21, 2018."},{"key":"ivp180007r3","unstructured":"PicchiA. The cost of Biogen\u2019s new drug: $750,000 per patient. CBS News website. https:\/\/www.cbsnews.com\/news\/the-cost-of-biogens-new-drug-spinraza-750000-per-patient\/. Published December 29, 2016. Accessed March 6, 2018."},{"key":"ivp180007r5","unstructured":"US Food and Drug Administration. Statistical review and evaluation: Clinical studies (NDA: 209531). 2016; https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000StatR.pdf. Accessed January 21, 2018."},{"key":"ivp180007r6","unstructured":"ClinicalTrials.gov. A study to assess the efficacy and safety of ISIS-SMN Rx in infants with spinal muscular atrophy (NCT02193074). https:\/\/clinicaltrials.gov\/archive\/NCT02193074\/2014_07_16. Accessed January 21, 2018."},{"key":"ivp180007r7","unstructured":"Center for Drug Evaluation and Research, US Food and Drug Administration. Application number: 209531Orig1s000: labeling. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000Lbl.pdf. Accessed January 21, 2018."},{"key":"ivp180007r8","unstructured":"WeismanR, SaltzmanJ. The new price of hope. Boston Globe. December 17, 2017. https:\/\/www.bostonglobe.com\/business\/2017\/12\/16\/spinrazamaincopy\/C8MJfCn2ZPS9wcQU3ziJCP\/story.html. Accessed January 21, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2678835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T16:37:14Z","timestamp":1534178234000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2018.0869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2018.0869","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}